Based in Hyderabad, India, Bharat Biotech is expanding its vaccine portfolio with a focus on antimicrobial resistance (AMR), a growing global health challenge. The company, known internationally for developing Covaxin during the Covid-19 pandemic, is now working on vaccines designed to prevent hospital-acquired infections, particularly in patients undergoing surgeries. According...
GSK Licenses Shigella Vaccine Candidate to Bharat Biotech
GSK has announced a licensing agreement with Hyderabad, India-based Bharat Biotech for its Shigella vaccine candidate, altSonflex 1-2-3. This collaboration signifies a step in addressing the global burden of Shigella, a bacterial infection that causes severe diarrhea and is responsible for thousands of deaths annually, predominantly among children under five....
Indian Company To Launch Oral Cholera Vaccine
Bharat Biotech, an Indian pharmaceutical company headquartered in Hyderabad, India, has announced the successful completion of a late-stage trial for its oral cholera vaccine, Hillchol. The company plans to launch the vaccine globally, with the goal of producing up to 200 million doses annually. This development comes at a crucial...
Bilthoven Biologicals of Netherlands and Bharat Biotech,roduce Polio Vaccines
Hyderabad India-based Bharat Biotech, a major vaccines and bio-therapeutics manufacturer in India, announced a collaboration with Bilthoven Biologicals B.V., the Netherlands-based wholly-owned subsidiary of Serum Institute of India. The partnership aims to strengthen the production and supply security of oral polio vaccines. Polio, or poliomyelitis, is a highly contagious and...
Bharat Biotech, University of Sydney Collaborate on Novel Vaccine Development
India's vaccine manufacturer, Bharat Biotech, announced a new collaboration with the University of Sydney Infectious Diseases Institute (Sydney ID) to advance vaccine research and development. The partnership aims to design innovative methodologies to tackle future epidemics and infectious diseases threats through strong academic-industry collaboration. Bharat Biotech and Sydney ID will...
India’s Bharat Biotech, Spain’s BioFabri, Partner for TB Vaccine
Hyderabad, India-based Bharat Biotech, announced a partnership with Spanish biopharmaceutical company BioFabri to develop, manufacture and distribute a new tuberculosis vaccine. MTBVAC, a live attenuated vaccine, is considered one of the most promising vaccine candidates in the current global TB vaccine pipeline. Biofabri is part of the Zendal Group based in...